Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 26, 2009
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancerA C Testa, M Ludovisi, R Manfredi, et al.
Oncology Research|November 8, 2001
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cellsG Ferrandina, P Filippini, C Ferlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patientsG Ferrandina, L Lauriola, M G Distefano, et al.
Transfusion|January 5, 2002
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSFL Pierelli, A Perillo, G Ferrandina, et al.
Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.
Molecular and Cellular Endocrinology|February 1, 1992
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cellsG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1993
Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancerG. Scambia, P. Benedetti Panici, G. Ferrandina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2007
Expression of CD133-1 and CD133-2 in ovarian cancerG Ferrandina, G Bonanno, L Pierelli, et al.
Clinical and Translational Radiation Oncology|March 24, 2025
Correlation between radiation dose to bone marrow subregions and acute hematologic toxicity inendometrial cancer treated with external beam radiotherapyR Autorino, D Cusumano, R M Rinaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 26, 2009
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancerA C Testa, M Ludovisi, R Manfredi, et al.
Oncology Research|November 8, 2001
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cellsG Ferrandina, P Filippini, C Ferlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patientsG Ferrandina, L Lauriola, M G Distefano, et al.
Transfusion|January 5, 2002
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSFL Pierelli, A Perillo, G Ferrandina, et al.
Cancer Research|October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitroG Ferrandina, B Melichar, A Loercher, et al.
Molecular and Cellular Endocrinology|February 1, 1992
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cellsG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1993
Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancerG. Scambia, P. Benedetti Panici, G. Ferrandina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2007
Expression of CD133-1 and CD133-2 in ovarian cancerG Ferrandina, G Bonanno, L Pierelli, et al.
Clinical and Translational Radiation Oncology|March 24, 2025
Correlation between radiation dose to bone marrow subregions and acute hematologic toxicity inendometrial cancer treated with external beam radiotherapyR Autorino, D Cusumano, R M Rinaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.
Pageof 18